ATE486633T1 - Feste pharmazeutische zusammensetzung mit telithromycin - Google Patents

Feste pharmazeutische zusammensetzung mit telithromycin

Info

Publication number: ATE486633T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; composition containing; solid pharmaceutical; telithromycin; containing telithromycin
Prior art date: 2005-02-25

Application number

AT06725981T

Other languages

English (en)

Inventor

Christian Desesquelle

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-25

Filing date

2006-02-23

Publication date

2010-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35106715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE486633(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-23 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2010-11-15 Application granted granted Critical

2010-11-15 Publication of ATE486633T1 publication Critical patent/ATE486633T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT06725981T 2005-02-25 2006-02-23 Feste pharmazeutische zusammensetzung mit telithromycin ATE486633T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0501936A FR2882522B1 (fr)	2005-02-25	2005-02-25	Composition pharmaceutique solide comprenant de la telithromycine
PCT/FR2006/000411 WO2006090067A1 (fr)	2005-02-25	2006-02-23	Composition pharmaceutique solide comprenant de la telithromycine

Publications (1)

Publication Number	Publication Date
ATE486633T1 true ATE486633T1 (de)	2010-11-15

Family

ID=35106715

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06725981T ATE486633T1 (de)	2005-02-25	2006-02-23	Feste pharmazeutische zusammensetzung mit telithromycin

Country Status (29)

Country	Link
US (2)	US20080113020A1 (de)
EP (1)	EP1855695B1 (de)
JP (1)	JP5063368B2 (de)
KR (1)	KR101346453B1 (de)
CN (1)	CN101180064B (de)
AR (1)	AR053144A1 (de)
AT (1)	ATE486633T1 (de)
AU (1)	AU2006217814B2 (de)
BR (1)	BRPI0608395A2 (de)
CA (1)	CA2598210A1 (de)
CY (1)	CY1111129T1 (de)
DE (1)	DE602006017975D1 (de)
DK (1)	DK1855695T3 (de)
ES (1)	ES2354906T3 (de)
FR (1)	FR2882522B1 (de)
HK (1)	HK1120412A1 (de)
HR (1)	HRP20110089T1 (de)
IL (1)	IL185251A (de)
ME (1)	ME01936B (de)
MX (1)	MX2007010405A (de)
MY (1)	MY145394A (de)
PL (1)	PL1855695T3 (de)
PT (1)	PT1855695E (de)
RS (1)	RS51578B (de)
RU (1)	RU2371184C2 (de)
SI (1)	SI1855695T1 (de)
TW (1)	TWI371280B (de)
UY (1)	UY29403A1 (de)
WO (1)	WO2006090067A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2882522B1 (fr)	2005-02-25	2007-04-13	Aventis Pharma Sa	Composition pharmaceutique solide comprenant de la telithromycine
CN102499936B (zh) *	2011-12-01	2013-06-26	西北农林科技大学	一种复方泰利霉素纳米乳口服液及其制备方法
WO2017061431A1 (ja) *	2015-10-05	2017-04-13	富山化学工業株式会社	ソリスロマイシンを含む錠剤
CN108778255B (zh) *	2016-01-12	2020-11-13	沃克哈特有限公司	药物组合物
WO2020021574A1 (en) *	2018-07-27	2020-01-30	Wockhardt Limited	Pharmaceutical compositions and methods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2719587B1 (fr)	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US6985594B1 (en) *	1999-06-15	2006-01-10	Hearing Enhancement Co., Llc.	Voice-to-remaining audio (VRA) interactive hearing aid and auxiliary equipment
FR2821747B1 (fr) *	2001-03-09	2004-07-02	Ethypharm Lab Prod Ethiques	Suspension de telithromycine a gout masque
FR2826274B1 (fr) *	2001-06-21	2003-09-26	Aventis Pharma Sa	Formulation pharmaceutique au gout masque et son procede de preparation
KR100487137B1 (ko) *	2002-07-12	2005-05-03	주식회사 하이닉스반도체	반도체 소자의 제조 방법
US20040013737A1 (en) *	2002-07-19	2004-01-22	Philippe Becourt	Taste masked oral composition of telithromycin
WO2004009059A1 (en) *	2002-07-19	2004-01-29	Aventis Pharma S.A.	Taste masked oral composition of telithromycin
AU2003274927A1 (en) *	2002-08-23	2004-03-11	Genome Therapeutics Corporation	Methods and reagents for preventing bacteremias
AU2003268330A1 (en) *	2002-08-29	2004-03-19	Activbiotics, Inc.	Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
GB0230034D0 (en) *	2002-12-23	2003-01-29	Biochemie Gmbh	Organic compounds
US20050037983A1 (en) *	2003-03-11	2005-02-17	Timothy Dinan	Compositions and methods for the treatment of depression and other affective disorders
JP2006522099A (ja) *	2003-04-04	2006-09-28	ファルマシアコーポレーション	複合粒状体からなる経口徐放性圧縮錠
FR2882522B1 (fr)	2005-02-25	2007-04-13	Aventis Pharma Sa	Composition pharmaceutique solide comprenant de la telithromycine

2005
- 2005-02-25 FR FR0501936A patent/FR2882522B1/fr not_active Expired - Fee Related
2006
- 2006-02-20 MY MYPI20060710A patent/MY145394A/en unknown
- 2006-02-23 WO PCT/FR2006/000411 patent/WO2006090067A1/fr active Application Filing
- 2006-02-23 DE DE602006017975T patent/DE602006017975D1/de active Active
- 2006-02-23 KR KR1020077021860A patent/KR101346453B1/ko not_active IP Right Cessation
- 2006-02-23 MX MX2007010405A patent/MX2007010405A/es active IP Right Grant
- 2006-02-23 SI SI200630881T patent/SI1855695T1/sl unknown
- 2006-02-23 RS RS20110038A patent/RS51578B/en unknown
- 2006-02-23 AT AT06725981T patent/ATE486633T1/de active
- 2006-02-23 RU RU2007135367/15A patent/RU2371184C2/ru not_active IP Right Cessation
- 2006-02-23 PL PL06725981T patent/PL1855695T3/pl unknown
- 2006-02-23 PT PT06725981T patent/PT1855695E/pt unknown
- 2006-02-23 AU AU2006217814A patent/AU2006217814B2/en not_active Ceased
- 2006-02-23 ES ES06725981T patent/ES2354906T3/es active Active
- 2006-02-23 BR BRPI0608395-1A patent/BRPI0608395A2/pt not_active IP Right Cessation
- 2006-02-23 AR ARP060100663A patent/AR053144A1/es unknown
- 2006-02-23 DK DK06725981.2T patent/DK1855695T3/da active
- 2006-02-23 CA CA002598210A patent/CA2598210A1/fr not_active Abandoned
- 2006-02-23 CN CN200680005962XA patent/CN101180064B/zh not_active Expired - Fee Related
- 2006-02-23 EP EP06725981A patent/EP1855695B1/de active Active
- 2006-02-23 JP JP2007556635A patent/JP5063368B2/ja not_active Expired - Fee Related
- 2006-02-24 TW TW095106185A patent/TWI371280B/zh not_active IP Right Cessation
- 2006-02-24 UY UY29403A patent/UY29403A1/es unknown
2007
- 2007-08-13 IL IL185251A patent/IL185251A/en not_active IP Right Cessation
- 2007-08-16 US US11/839,719 patent/US20080113020A1/en not_active Abandoned
2008
- 2008-11-06 HK HK08112195.0A patent/HK1120412A1/xx not_active IP Right Cessation
2011
- 2011-01-21 CY CY20111100068T patent/CY1111129T1/el unknown
- 2011-02-03 HR HR20110089T patent/HRP20110089T1/hr unknown
2013
- 2013-08-30 US US14/014,677 patent/US8962021B2/en not_active Expired - Fee Related
2016
- 2016-10-19 ME MEP-2011-213A patent/ME01936B/me unknown

Also Published As

Publication number	Publication date
PL1855695T3 (pl)	2011-04-29
IL185251A0 (en)	2008-02-09
JP2008531529A (ja)	2008-08-14
AR053144A1 (es)	2007-04-25
HK1120412A1 (en)	2009-04-03
AU2006217814B2 (en)	2011-08-11
JP5063368B2 (ja)	2012-10-31
DK1855695T3 (da)	2011-02-21
BRPI0608395A2 (pt)	2009-12-29
ES2354906T3 (es)	2011-03-21
US20130344151A1 (en)	2013-12-26
US8962021B2 (en)	2015-02-24
TWI371280B (en)	2012-09-01
US20080113020A1 (en)	2008-05-15
EP1855695A1 (de)	2007-11-21
ME01936B (en)	2016-10-19
RU2371184C2 (ru)	2009-10-27
RU2007135367A (ru)	2009-03-27
TW200640472A (en)	2006-12-01
CY1111129T1 (el)	2015-06-11
EP1855695B1 (de)	2010-11-03
PT1855695E (pt)	2011-01-19
FR2882522A1 (fr)	2006-09-01
IL185251A (en)	2012-10-31
SI1855695T1 (sl)	2011-02-28
DE602006017975D1 (de)	2010-12-16
UY29403A1 (es)	2006-10-02
CN101180064B (zh)	2010-09-22
MY145394A (en)	2012-02-15
CA2598210A1 (fr)	2006-08-31
KR20070106581A (ko)	2007-11-01
HRP20110089T1 (hr)	2011-03-31
MX2007010405A (es)	2007-10-17
KR101346453B1 (ko)	2014-01-02
FR2882522B1 (fr)	2007-04-13
RS51578B (en)	2011-08-31
AU2006217814A1 (en)	2006-08-31
CN101180064A (zh)	2008-05-14
WO2006090067A1 (fr)	2006-08-31

Publication	Publication Date	Title
RU2398586C3 (ru)	2017-10-04	Фармацевтическая композиция
ITBO20050123A1 (it)	2005-06-06	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no)	2007-11-05	Farmasøytiske formuleringer
ATE517619T1 (de)	2011-08-15	Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
BRPI0616703A2 (pt)	2016-09-06	forma de dosagem farmacêutica
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
EP1992348A4 (de)	2009-09-23	Pharmazeutische kombination
DK1957073T3 (da)	2014-05-12	Lægemiddel
ATE453384T1 (de)	2010-01-15	Neue dosierformulierung
ATE493119T1 (de)	2011-01-15	Pharmazeutische zusammensetzung
IL186336A0 (en)	2008-01-20	Pharmaceutical composition
ATE483702T1 (de)	2010-10-15	Neue pharmazeutische verbindungen
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
EP1987825A4 (de)	2012-10-17	Pharmazeutische zusammensetzung mit oseltamivirphosphat
EP1937255A4 (de)	2013-06-26	Pharmazeutische zusammensetzung
ATE480227T1 (de)	2010-09-15	Pharmazeutische zusammensetzungen mit quetiapinfumarat
EP1862184A4 (de)	2012-12-19	Pharmazeutische zusammensetzung
BRPI0614413A2 (pt)	2016-11-22	composto, e, composição farmacêutica
ATE486633T1 (de)	2010-11-15	Feste pharmazeutische zusammensetzung mit telithromycin
EP2156832A4 (de)	2010-11-24	Pharmazeutische zusammensetzung
BRPI0614412A2 (pt)	2016-11-22	composto, e, composição farmacêutica
ATE489943T1 (de)	2010-12-15	Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
ATE552005T1 (de)	2012-04-15	Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina

Legal Events

Date	Code	Title	Description
2011-05-15	UEP	Publication of translation of european patent specification	Ref document number: 1855695 Country of ref document: EP

Date

Code

Title

Description

2011-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1855695

Country of ref document: EP